Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Mallinckrodt is estimated to have a major share in the global market with 62%.
The global Inhaled Nitric Oxide market is valued at 924.9 million US$ in 2020 is expected to reach 1626.2 million US$ by the end of 2026, growing at a CAGR of 8.3% during 2021-2026.
This report focuses on Inhaled Nitric Oxide volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Inhaled Nitric Oxide market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America and Europe. etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Inhaled Nitric Oxide market is segmented into
800 ppm
100 ppm
Other
The segment of 800 ppm holds a comparatively larger share in global market, which accounts for about 55%.
Segment by Application
ARDS
PPHN
Other Diseases
The PPHN holds an important share in terms of applications, and accounts for 56% of the market share.
Global Inhaled Nitric Oxide Market: Regional Analysis
The Inhaled Nitric Oxide market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Inhaled Nitric Oxide market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Inhaled Nitric Oxide Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Inhaled Nitric Oxide market include:
Mallinckrodt
Praxair
Air Liquide
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Mallinckrodt is estimated to have a major share in the global market with 62%.
The global Inhaled Nitric Oxide market is valued at 924.9 million US$ in 2020 is expected to reach 1626.2 million US$ by the end of 2026, growing at a CAGR of 8.3% during 2021-2026.
This report focuses on Inhaled Nitric Oxide volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Inhaled Nitric Oxide market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America and Europe. etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Inhaled Nitric Oxide market is segmented into
800 ppm
100 ppm
Other
The segment of 800 ppm holds a comparatively larger share in global market, which accounts for about 55%.
Segment by Application
ARDS
PPHN
Other Diseases
The PPHN holds an important share in terms of applications, and accounts for 56% of the market share.
Global Inhaled Nitric Oxide Market: Regional Analysis
The Inhaled Nitric Oxide market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Inhaled Nitric Oxide market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Inhaled Nitric Oxide Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Inhaled Nitric Oxide market include:
Mallinckrodt
Praxair
Air Liquide
Table of Contents
1 Inhaled Nitric Oxide Market Overview
1.1 Product Overview and Scope of Inhaled Nitric Oxide
1.2 Inhaled Nitric Oxide Segment by Type
1.2.1 Global Inhaled Nitric Oxide Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Other
1.3 Inhaled Nitric Oxide Segment by Application
1.3.1 Inhaled Nitric Oxide Sales Comparison by Application: 2020 VS 2026
1.3.2 ARDS
1.3.3 PPHN
1.3.4 Other Diseases
1.4 Global Inhaled Nitric Oxide Market Size Estimates and Forecasts
1.4.1 Global Inhaled Nitric Oxide Revenue 2015-2026
1.4.2 Global Inhaled Nitric Oxide Sales 2015-2026
1.4.3 Inhaled Nitric Oxide Market Size by Region: 2020 Versus 2026
2 Global Inhaled Nitric Oxide Market Competition by Manufacturers
2.1 Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2015-2020)
2.2 Global Inhaled Nitric Oxide Revenue Share by Manufacturers (2015-2020)
2.3 Global Inhaled Nitric Oxide Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Inhaled Nitric Oxide Manufacturing Sites, Area Served, Product Type
2.5 Inhaled Nitric Oxide Market Competitive Situation and Trends
2.5.1 Inhaled Nitric Oxide Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Inhaled Nitric Oxide Players (Opinion Leaders)
3 Inhaled Nitric Oxide Retrospective Market Scenario by Region
3.1 Global Inhaled Nitric Oxide Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Inhaled Nitric Oxide Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Inhaled Nitric Oxide Market Facts & Figures by Country
3.3.1 North America Inhaled Nitric Oxide Sales by Country
3.3.2 North America Inhaled Nitric Oxide Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Inhaled Nitric Oxide Market Facts & Figures by Country
3.4.1 Europe Inhaled Nitric Oxide Sales by Country
3.4.2 Europe Inhaled Nitric Oxide Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Inhaled Nitric Oxide Market Facts & Figures by Region
3.5.1 Asia Pacific Inhaled Nitric Oxide Sales by Region
3.5.2 Asia Pacific Inhaled Nitric Oxide Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Inhaled Nitric Oxide Market Facts & Figures by Country
3.6.1 Latin America Inhaled Nitric Oxide Sales by Country
3.6.2 Latin America Inhaled Nitric Oxide Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Inhaled Nitric Oxide Market Facts & Figures by Country
3.7.1 Middle East and Africa Inhaled Nitric Oxide Sales by Country
3.7.2 Middle East and Africa Inhaled Nitric Oxide Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Inhaled Nitric Oxide Historic Market Analysis by Type
4.1 Global Inhaled Nitric Oxide Sales Market Share by Type (2015-2020)
4.2 Global Inhaled Nitric Oxide Revenue Market Share by Type (2015-2020)
4.3 Global Inhaled Nitric Oxide Price Market Share by Type (2015-2020)
4.4 Global Inhaled Nitric Oxide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Inhaled Nitric Oxide Historic Market Analysis by Application
5.1 Global Inhaled Nitric Oxide Sales Market Share by Application (2015-2020)
5.2 Global Inhaled Nitric Oxide Revenue Market Share by Application (2015-2020)
5.3 Global Inhaled Nitric Oxide Price by Application (2015-2020)
6 Company Profiles and Key Figures in Inhaled Nitric Oxide Business
6.1 Mallinckrodt
6.1.1 Corporation Information
6.1.2 Mallinckrodt Description, Business Overview and Total Revenue
6.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Mallinckrodt Products Offered
6.1.5 Mallinckrodt Recent Development
6.2 Praxair
6.2.1 Praxair Inhaled Nitric Oxide Production Sites and Area Served
6.2.2 Praxair Description, Business Overview and Total Revenue
6.2.3 Praxair Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Praxair Products Offered
6.2.5 Praxair Recent Development
6.3 Air Liquide
6.3.1 Air Liquide Inhaled Nitric Oxide Production Sites and Area Served
6.3.2 Air Liquide Description, Business Overview and Total Revenue
6.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Air Liquide Products Offered
6.3.5 Air Liquide Recent Development
7 Inhaled Nitric Oxide Manufacturing Cost Analysis
7.1 Inhaled Nitric Oxide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Inhaled Nitric Oxide
7.4 Inhaled Nitric Oxide Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Inhaled Nitric Oxide Distributors List
8.3 Inhaled Nitric Oxide Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Inhaled Nitric Oxide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Inhaled Nitric Oxide by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Inhaled Nitric Oxide by Type (2021-2026)
10.2 Inhaled Nitric Oxide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Inhaled Nitric Oxide by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Inhaled Nitric Oxide by Application (2021-2026)
10.3 Inhaled Nitric Oxide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Inhaled Nitric Oxide by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Inhaled Nitric Oxide by Region (2021-2026)
10.4 North America Inhaled Nitric Oxide Estimates and Projections (2021-2026)
10.5 Europe Inhaled Nitric Oxide Estimates and Projections (2021-2026)
10.6 Asia Pacific Inhaled Nitric Oxide Estimates and Projections (2021-2026)
10.7 Latin America Inhaled Nitric Oxide Estimates and Projections (2021-2026)
10.8 Middle East and Africa Inhaled Nitric Oxide Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1 Inhaled Nitric Oxide Market Overview
1.1 Product Overview and Scope of Inhaled Nitric Oxide
1.2 Inhaled Nitric Oxide Segment by Type
1.2.1 Global Inhaled Nitric Oxide Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Other
1.3 Inhaled Nitric Oxide Segment by Application
1.3.1 Inhaled Nitric Oxide Sales Comparison by Application: 2020 VS 2026
1.3.2 ARDS
1.3.3 PPHN
1.3.4 Other Diseases
1.4 Global Inhaled Nitric Oxide Market Size Estimates and Forecasts
1.4.1 Global Inhaled Nitric Oxide Revenue 2015-2026
1.4.2 Global Inhaled Nitric Oxide Sales 2015-2026
1.4.3 Inhaled Nitric Oxide Market Size by Region: 2020 Versus 2026
2 Global Inhaled Nitric Oxide Market Competition by Manufacturers
2.1 Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2015-2020)
2.2 Global Inhaled Nitric Oxide Revenue Share by Manufacturers (2015-2020)
2.3 Global Inhaled Nitric Oxide Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Inhaled Nitric Oxide Manufacturing Sites, Area Served, Product Type
2.5 Inhaled Nitric Oxide Market Competitive Situation and Trends
2.5.1 Inhaled Nitric Oxide Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Inhaled Nitric Oxide Players (Opinion Leaders)
3 Inhaled Nitric Oxide Retrospective Market Scenario by Region
3.1 Global Inhaled Nitric Oxide Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Inhaled Nitric Oxide Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Inhaled Nitric Oxide Market Facts & Figures by Country
3.3.1 North America Inhaled Nitric Oxide Sales by Country
3.3.2 North America Inhaled Nitric Oxide Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Inhaled Nitric Oxide Market Facts & Figures by Country
3.4.1 Europe Inhaled Nitric Oxide Sales by Country
3.4.2 Europe Inhaled Nitric Oxide Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Inhaled Nitric Oxide Market Facts & Figures by Region
3.5.1 Asia Pacific Inhaled Nitric Oxide Sales by Region
3.5.2 Asia Pacific Inhaled Nitric Oxide Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Inhaled Nitric Oxide Market Facts & Figures by Country
3.6.1 Latin America Inhaled Nitric Oxide Sales by Country
3.6.2 Latin America Inhaled Nitric Oxide Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Inhaled Nitric Oxide Market Facts & Figures by Country
3.7.1 Middle East and Africa Inhaled Nitric Oxide Sales by Country
3.7.2 Middle East and Africa Inhaled Nitric Oxide Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Inhaled Nitric Oxide Historic Market Analysis by Type
4.1 Global Inhaled Nitric Oxide Sales Market Share by Type (2015-2020)
4.2 Global Inhaled Nitric Oxide Revenue Market Share by Type (2015-2020)
4.3 Global Inhaled Nitric Oxide Price Market Share by Type (2015-2020)
4.4 Global Inhaled Nitric Oxide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Inhaled Nitric Oxide Historic Market Analysis by Application
5.1 Global Inhaled Nitric Oxide Sales Market Share by Application (2015-2020)
5.2 Global Inhaled Nitric Oxide Revenue Market Share by Application (2015-2020)
5.3 Global Inhaled Nitric Oxide Price by Application (2015-2020)
6 Company Profiles and Key Figures in Inhaled Nitric Oxide Business
6.1 Mallinckrodt
6.1.1 Corporation Information
6.1.2 Mallinckrodt Description, Business Overview and Total Revenue
6.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Mallinckrodt Products Offered
6.1.5 Mallinckrodt Recent Development
6.2 Praxair
6.2.1 Praxair Inhaled Nitric Oxide Production Sites and Area Served
6.2.2 Praxair Description, Business Overview and Total Revenue
6.2.3 Praxair Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Praxair Products Offered
6.2.5 Praxair Recent Development
6.3 Air Liquide
6.3.1 Air Liquide Inhaled Nitric Oxide Production Sites and Area Served
6.3.2 Air Liquide Description, Business Overview and Total Revenue
6.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Air Liquide Products Offered
6.3.5 Air Liquide Recent Development
7 Inhaled Nitric Oxide Manufacturing Cost Analysis
7.1 Inhaled Nitric Oxide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Inhaled Nitric Oxide
7.4 Inhaled Nitric Oxide Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Inhaled Nitric Oxide Distributors List
8.3 Inhaled Nitric Oxide Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Inhaled Nitric Oxide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Inhaled Nitric Oxide by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Inhaled Nitric Oxide by Type (2021-2026)
10.2 Inhaled Nitric Oxide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Inhaled Nitric Oxide by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Inhaled Nitric Oxide by Application (2021-2026)
10.3 Inhaled Nitric Oxide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Inhaled Nitric Oxide by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Inhaled Nitric Oxide by Region (2021-2026)
10.4 North America Inhaled Nitric Oxide Estimates and Projections (2021-2026)
10.5 Europe Inhaled Nitric Oxide Estimates and Projections (2021-2026)
10.6 Asia Pacific Inhaled Nitric Oxide Estimates and Projections (2021-2026)
10.7 Latin America Inhaled Nitric Oxide Estimates and Projections (2021-2026)
10.8 Middle East and Africa Inhaled Nitric Oxide Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.